Stock listing

Innocan Pharma Corporation

Selected listing: INNO · CSE · CAD · CA

Innocan Pharma Corporation (CSE:INNO), Health Technology. Latest release Oct 1, 2026: VALITIC(TM) Featured by BuzzFeed for "Magical Results," Further…

INNO:CSECADCAUpdated October 2, 2026

Ticker: CSE:INNO
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: CSE
Currency: CAD

About Innocan Pharma Corporation

Innocan Pharma Corporation, trading under the ticker INNO, is a public company based in Canada. Innocan focuses on developing innovative pharmaceutical products, particularly in the field of cannabinoid-based therapies.

Latest news from Innocan Pharma Corporation

VALITIC(TM) Featured by BuzzFeed for "Magical Results," Further Strengthening Consumer Brand Momentum

October 1, 2026

Innocan Pharma Announces First Tranche Closing of Private Placement of Units

September 23, 2026

Innocan Pharma Announces Private Placement of Units

September 9, 2026

Innocan Pharma Announces Second Quarter Fiscal year 2026 Results, With Revenue of US$5.25M (CAD 7.3M)

August 31, 2026

Innocan Pharma Posts Strong Q1 2026 Results*, With Revenue Surging 29.7% to US$6.47M

May 27, 2026

All Innocan Pharma Corporation news →

Research Innocan Pharma Corporation

Innocan Pharma Corporation company profile

View the public company page for Innocan Pharma Corporation on 6ix.

Innocan Pharma Corporation news

Read company news and market updates connected to Innocan Pharma Corporation.

Innocan Pharma Corporation investor events

Find investor webinars, events, and replay context for Innocan Pharma Corporation.